The FDA's RTCT initiative is bringing regulators closer to live trial data. The real question is whether trial infrastructure can keep pace.

Biorce is launching Aika 2.0 at ASCO 2026 with a ride experience, introducing the end-to-end operating system for clinical trials.

XTalks webinar with Pedro Coelho (Biorce CEO), Paolo Martini (Two Hundred Thousand Consulting LLC), and Bruno Gagnon (Spruce)

Biorce makes its mark with a bold conference as the life sciences industry gathers in Boston for a landmark week of events.

Forbes Spain includes Biorce leadership team into the 100 most creative people in business 2026 (news article in Spanish).

The New Barcelona Post news article about Biorce (news article in Spanish).

Journal of Medical Internet Research highlighting Biorce.

Crunchbase news article featuring Biorce.

4YFN news article about Biorce winning the prestigious MWC 4YFN 2026 award.

Biorce expands its U.S. footprint and AI R&D operations by opening a new office in Austin, Texas.

CEO Pedro Coelho talks with Edwin Moses, ex-Ablynx CEO, who grew it to 500 staff before Sanofi's $4.8B acquisition.

UpNext Global news article about Biorce.

MWC GSMA news article about Biorce.

The EU AI Act is becoming fully operational in August 2026. But what are the implications of the EU AI Act for pharma at this stage?

Handelsblatt news article about Biorce (news article in German).